Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-18-046095

Options or other derivatives

  • Chief Operating Officer acquired 145,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MacKenzie Lloyd · Chief Operating Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-08-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +145,000 145,000 D
Loading xslF345X03/doc4.xml…